Paris, France: Global Business Project (Focus: Innovation, New Venture, Marketing, Government - 2016)
Cornell University and Queen's University Joint Double MBA program.

Paris, France: Global Business Project (Focus: Innovation, New Venture, Marketing, Government - 2016)

College of Liberal Arts: B.A. in Political Science & Gov't, Certificate: International Relations. (Degree Completed)
Mexico: Studied abroad Program: (Focus: Politics, Culture, and Educational Systems – 2007-08)

Criminal Justice (Sociology Department)
Dean's List

Provide leadership and oversight to achieve the highest levels of customer service exemplified by launching East Coast operations from the ground-up in the Greater Boston area. Manage 25+ clinical, laboratory, donor recruiting, accounting, sales and marketing staff, including staffing, procedure development, and operational training. Develop business within the Eastern U.S. and Europe to boost customers and revenue diversification. Provide CEO and executives with weekly project status updates to foster positive communications and alignment. Accountable for AOP $22M serving Biotech/Pharma and Academic clients.

• Licensed a clinical laboratory through Massachusetts Department of Public Health and CLIA.
• Increased East Coast and European sales by 50% and doubled production capacity through more efficient processes, leading to increased revenue generation.
• Negotiated and implemented supply chain contracts with CDMO and CRO Key Accounts, providing Human Biological Samples for R&D and Drug discovery/manufacturing purposes.
o Manage ~35 key accounts valued at $22M, with total company revenue of ~$45M.
• Trained staff on current SOPs while complying with GCP and ISO standards.

Developed, managed, and led partnerships by communicating vision, collaborating with leadership to develop and meet business objectives. Oversaw and developed 300+ clinical and administrative employees and communicated updates on performance to executive teams. Managed the annual operating planning process in accordance with financial guidelines and goals to ensure the attainment of strategic objectives.

• Achieved regional goals by reaching >500K units of blood and platelets apheresis collections at 118%, resulting in largest producer in the U.S. - exported excess supplies to partnering regions.
• Achieved targeted AOP of $70M+, servicing 120 hospital accounts in MA/CT region (FY14, FY15).
• Launched five brand new blood collection clinical facilities, and a manufacturing laboratory from the ground up; met operational, quality goals (GCP and ISO) and FDA audits without any findings.
• Merged Massachusetts and Connecticut blood services regions under one executive team, served as the Designee for Regional CEO – monitored performances of Directors and Sr. Managers

Equipment Systems, Technologies, & Validations

System Administrator: Directed and evaluated departmental operations, including patient care delivery, information technologies, and service levels to achieve performance and quality control objectives. Developed 20+ staff (technical engineers, biomedical technicians, and field supervisors/managers), including hiring, orientation, and evaluation. Prepared, monitored, and evaluated departmental budgets.

• Managed budget of medical equipment and supplies - $10M annually.
• Implemented a blood processing national standardization project (BioARCH R1, & R2) in six different regions across the U.S. ensuring all staff training, equipment installed/validated, and QA approved.
• Reduced CAPEX by 10% annually during tenure, identifying best practices and labor efficiencies.
• Trained Northeast Division staff in GCP, GMP, Problem Management and Smart CAPA procedures, resulting in no FDA or CLIA findings for equipment and validation system audits

Developed a high-performing team with improved morale and engagement. Led planning/purchasing teams to develop and execute a manufacturing schedule to meet customer demands. Partnered with departments to drive improvements in equipment performance. Initiated investigations into process failures, product failures, and safety incidents; identified and implemented corrective and preventive actions (Smart CAPA).

• Increased blood manufacturing efficiencies by utilizing LEAN manufacturing practices and staff training effectiveness while complying with GMP and ISO practices
• Increased production by 12% producing more red blood cells than legacy years